BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3261587)

  • 1. Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients.
    Callen JP; Klein J
    Arthritis Rheum; 1988 Aug; 31(8):1007-13. PubMed ID: 3261587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute cutaneous lupus erythematosus-immunogenetic associations.
    Watson RM; Talwar P; Alexander E; Bias WB; Provost TT
    J Autoimmun; 1991 Feb; 4(1):73-85. PubMed ID: 2031665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subacute cutaneous lupus erythematosus. Clinical, serologic, and immunogenetic studies of forty-nine patients seen in a nonreferral setting.
    Callen JP; Kulick KB; Stelzer G; Fowler JF
    J Am Acad Dermatol; 1986 Dec; 15(6):1227-37. PubMed ID: 3543071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subacute cutaneous lupus erythematosus: clinical aspects, immunology and therapy].
    Ruzicka T; Bieber T; Meurer M
    Wien Klin Wochenschr; 1987 Dec; 99(23):802-7. PubMed ID: 3324494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, serologic and immunogenetic studies in patients with chronic cutaneous (discoid) lupus erythematosus who have verrucous and/or hypertrophic skin lesions.
    Spann CR; Callen JP; Klein JB; Kulick KB
    J Rheumatol; 1988 Feb; 15(2):256-61. PubMed ID: 3258916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Questions pertaining to the true frequencies with which anti-Ro/SS-A autoantibody and the HLA-DR3 phenotype occur in subacute cutaneous lupus erythematosus patients.
    Sontheimer RD
    J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):130-4. PubMed ID: 3492520
    [No Abstract]   [Full Text] [Related]  

  • 7. Subacute cutaneous lupus erythematosus.
    David-Bajar KM
    J Invest Dermatol; 1993 Jan; 100(1):2S-8S. PubMed ID: 8423385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
    Chlebus E; Wolska H; Blaszczyk M; Jablonska S
    J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus.
    Sontheimer RD; Maddison PJ; Reichlin M; Jordon RE; Stastny P; Gilliam JN
    Ann Intern Med; 1982 Nov; 97(5):664-71. PubMed ID: 6982644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenetic findings in cutaneous lupus erythematosus.
    Bielsa I; Herrero C; Ercilla G; Collado A; Font J; Ingelmo M; Mascaró JM
    J Am Acad Dermatol; 1991 Aug; 25(2 Pt 1):251-7. PubMed ID: 1918462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute cutaneous lupus-erythematosus in childhood.
    Siamopoulou-Mavridou A; Stefanou D; Drosos AA
    Clin Rheumatol; 1989 Dec; 8(4):533-7. PubMed ID: 2612123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U1RNP antibody-positive neonatal lupus. A report of two cases with immunogenetic studies.
    Dugan EM; Tunnessen WW; Honig PJ; Watson RM
    Arch Dermatol; 1992 Nov; 128(11):1490-4. PubMed ID: 1444503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Bonsmann G; Schiller M; Luger TA; Ständer S
    J Am Acad Dermatol; 2001 Jun; 44(6):925-31. PubMed ID: 11369902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subacute cutaneous lupus erythematosus on the lines of Blaschko.
    Röckmann H; Feller G; Schadendorf D; Goerdt S
    Eur J Dermatol; 2006; 16(3):302-6. PubMed ID: 16709500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subacute cutaneous lupus erythematosus in Greece. A clinical, serological and genetic study.
    Drosos AA; Dimou GS; Siamopoulou-Mavridou A; Hatzis J; Moutsopoulos HM
    Ann Med Interne (Paris); 1990; 141(5):421-4. PubMed ID: 2256585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced lupus erythematosus.
    Marzano AV; Tavecchio S; Menicanti C; Crosti C
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A characteristic cutaneous direct immunofluorescent pattern associated with Ro(SS-A) antibodies in subacute cutaneous lupus erythematosus.
    Valeski JE; Kumar V; Forman AB; Beutner EH; Chorzelski TP
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):194-8. PubMed ID: 1430355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subacute cutaneous lupus erythematosus--clinical, histopathological and immunophenotypical study of five cases.
    Vázquez-Doval J; Ruiz de Erenchun F; Sánchez-Ibarrola A; Contreras F; Soto de Delás J; Quintanilla E
    J Investig Allergol Clin Immunol; 1992; 2(1):27-32. PubMed ID: 1342879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute cutaneous lupus erythematosus in multiple members of a family with C2 deficiency.
    Callen JP; Hodge SJ; Kulick KB; Stelzer G; Buchino JJ
    Arch Dermatol; 1987 Jan; 123(1):66-70. PubMed ID: 3467658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annular erythema associated with lupus erythematosus/Sjögren's syndrome.
    Watanabe T; Tsuchida T; Ito Y; Kanda N; Ueda Y; Tamaki K
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):214-8. PubMed ID: 9039171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.